{"id":"NCT00194987","sponsor":"Weill Medical College of Cornell University","briefTitle":"A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia","officialTitle":"A Randomized Multicenter Trial of Antenatal Treatment of Alloimmune Thrombocytopenia","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2001-04","primaryCompletion":"2015-06-30","completion":"2015-06-30","firstPosted":"2005-09-19","resultsPosted":"2018-11-07","lastUpdate":"2018-11-07"},"enrollment":102,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Alloimmune Thrombocytopenia","Fetal Alloimmune Thrombocytopenia"],"interventions":[{"type":"DRUG","name":"IVIG (Intravenous Immunoglobulin)","otherNames":[]},{"type":"DRUG","name":"prednisone","otherNames":[]}],"arms":[{"label":"IVIG x 2","type":"EXPERIMENTAL"},{"label":"IVIG x 1 + prednisone","type":"EXPERIMENTAL"}],"summary":"The purposes of this study are to provide medical management by giving treatment to the mother that will bring up the fetal platelet count and to minimize the number of invasive procedures to the fetus (which may result in serious fetal injuries).","primaryOutcome":{"measure":"Number of Newborns With a Birth Platelet Count > 50,000/uL","timeFrame":"32-40 weeks (the endpoint is the birth which is not at the same number of weeks for all of the babies. This is why the weeks are not listed specifically eg week 40","effectByArm":[{"arm":"IVIG 1g/kg Twice Per Week","deltaMin":48,"sd":null},{"arm":"IVIG 1g/k/Week and Prednisone 0.5 mg/kg/Day","deltaMin":47,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["27611703","17666597"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":51},"commonTop":["headache","hypertension","IVIG dose error","diabetes mellitus","jaw tightness"]}}